Geron (NasdaqGS:GERN) 2025 Conference November 11, 2025 10:40 AM ET Speaker2All right, we're going to go ahead and get started. I'm Stephen Willie, one of the senior biotech analysts here at Stifel. I'm glad to have with us here for the next discussion Geron. I have Harout Semerjian, who is the new CEO of Geron as of a few months ago, and Joseph Eid, who runs up the R&D effort and has a lot of experience in the hematology space. Harout, I think most folks are pretty familiar with the Geron story, but maybe ...